NASDAQ:KTRA
Delisted

Kintara Therapeutics Stock Predictions

etoro logo Buy KTRA
*Your capital is at risk
$0.215
+0 (+0%)
At Close: Jan 16, 2025
Currently predicting for Fri, 5 Jun 2026

KTRA Prediction Chart

KTRA Predictions History

Latest community submissions for KTRA.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 7, 2024 $0.101 +6.03% $0.0945 X 93.19% 0
Mar 7, 2024 $0.0988 +3.77% $0.0945 X 95.46% 0
JS JS Pro
Mar 7, 2024 $0.0930 -2.31% $0.0945 V 98.41% 1
JS JS Pro
Mar 6, 2024 $0.105 +2.54% $0.0952 X 89.71% 0
AlexVel AlexVel Pro
Mar 6, 2024 $0.0963 -5.96% $0.0952 V 98.84% 2
Mar 6, 2024 $0.0964 -5.84% $0.0952 V 98.72% 2
Mar 6, 2024 $0.0987 -3.65% $0.0952 V 96.36% 1
AlexVel AlexVel Pro
Mar 5, 2024 $0.0949 -0.21% $0.102 X 92.67% 0
JS JS Pro
Mar 5, 2024 $0.0900 -5.36% $0.102 X 87.89% 0
Mar 5, 2024 $0.101 +6.45% $0.102 V 98.86% 2
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KTRA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KINTARA THERAPEUTICS INC.
Kintara Therapeutics
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE